The antiserum was produced against synthesized peptide derived from human Acetyl-CoA Carboxylase around the phosphorylation site of Ser80. AA range:46-95

Phospho-ACCα (S80) Polyclonal Antibody detects endogenous levels of ACCα protein only when phosphorylated at S80.The name of modified sites may be influenced by many factors, such as species (the modified site was not originally found in human samples) and the change of protein sequence (the previous protein sequence is incomplete, and the protein sequence may be prolonged with the development of protein sequencing technology). When naming, we will use the "numbers" in historical reference to keep the sites consistent with the reports. The antibody binds to the following modification sequence (lowercase letters are modification sites):SMsGL

ACACA

Acetyl-CoA carboxylase 1;ACC1;Acetyl-Coenzyme A carboxylase alpha;ACC-alpha;

ACACA ;
ACAC ;
ACC1 ;
ACCA ;
Acetyl-CoA carboxylase 1 ;
ACC-alpha ;

Acetyl-CoA carboxylase (ACC) is a complex multifunctional enzyme system. ACC is a biotin-containing enzyme which catalyzes the carboxylation of acetyl-CoA to malonyl-CoA , the rate-limiting step in fatty acid synthesis. There are two ACC forms , alpha and beta , encoded by two different genes. ACC-alpha is highly enriched in lipogenic tissues. The enzyme is under long term control at the transcriptional and translational levels and under short term regulation by the phosphorylation/dephosphorylation of targeted serine residues and by allosteric transformation by citrate or palmitoyl-CoA. Multiple alternatively spliced transcript variants divergent in the 5' sequence and encoding distinct isoforms have been found for this gene. [provided by RefSeq , Jul 2008] ,

Catalytic activity:ATP + acetyl-CoA + HCO (3) (-) = ADP + phosphate + malonyl-CoA. ,Catalytic activity:ATP + biotin-carboxyl-carrier protein + CO (2) = ADP + phosphate + carboxybiotin-carboxyl-carrier protein. ,cofactor:Binds 2 manganese ions per subunit. ,cofactor:Biotin. ,Disease:Defects in ACACA are a cause of ACACA deficiency [MIM:200350]; also called ACAC or ACC deficiency. ACACA deficiency is an inborn error of de novo fatty acid synthesis. The disorder is associated with severe brain damage , persistent myopathy and poor growth. ,enzyme regulation:By phosphorylation. ,Function:Catalyzes the rate-limiting reaction in the biogenesis of long-chain fatty acids. Carries out three functions: biotin carboxyl carrier protein , biotin carboxylase and carboxyltransferase. ,online information:Acetyl-CoA carboxylase entry ,pathway:Lipid metabolism; malonyl-CoA biosynthesis; malonyl-CoA from acetyl-CoA: step 1/1. ,PTM:Phosphorylation on Ser-1263 is required for interaction with BRCA1. ,similarity:Contains 1 ATP-grasp domain. ,similarity:Contains 1 biotin carboxylation domain. ,similarity:Contains 1 biotinyl-binding domain. ,similarity:Contains 1 carboxyltransferase domain. ,subunit:Interacts in its inactive phosphorylated form with the BRCT domains of BRCA1 which prevents ACACA dephosphorylation and inhibits lipid synthesis. ,tissue specificity:Expressed in brain , placental , skeletal muscle , renal , pancreatic and adipose tissues; expressed at low level in pulmonary tissue; not detected in the liver. ,

Cytoplasm , cytosol .

>>Fatty acid biosynthesis ;
>>Pyruvate metabolism ;
>>Propanoate metabolism ;
>>Metabolic pathways ;
>>Fatty acid metabolism ;
>>AMPK signaling pathway ;
>>Insulin signaling pathway ;
>>Glucagon signaling pathway ;
>>Alcoholic liver disease